Tag: In the News,clinical findings immunotherapy,immunotherapy test,innovationews story,melanoma,nivolumab,nivolumab test

Innovationews – “Biodesix Inc.  announced new clinical findings that show its novel investigational test, BDX008 – based on profiling serum proteins – identifies patients with advanced melanoma who are more likely to have longer progression-free and overall survival with nivolumb therapy.” Read the full story.